Globally, 49 million people suffer from sepsis each year. This leads to 11 millions deaths, which equates to 20% of deaths around the world.
Rapid detection for sepsis is crucial. Every hour this disease goes untreated, the chances of mortality go up by 8%.
To learn more about the disease, the difficulties of diagnosis and the importance of rapid detection; we sat down with Stefan Willemsen, former President and CEO of the US subsidiary of bioMerieux and board member of Sepsis Alliance.
We also spoke to Jonathon Romanowsky, co-founder of Inflammatix - who are one of the most innovative start-ups working within sepsis right now, applying bioinformatics and machine learning to their test.
Our latest video on liquid biopsy, featuring Business Development Consultant in Oncology and Liquid Biopsy, Dale Yuzuki, is also available to watch now.
If you found this video interesting and would like to talk to us more about the innovations you've seen in diagnostics, please contacts us via email at Eleanor.Doolin@lifesci-cm.com or Adam.Hargreaves@lifesci-cm.com.
You can find more of Eleanor's content on her consultant page.
You can find more of Adam's content on his consultant page.
Featuring CEO & Co-Founder of FlexMedical Solutions, Kevin Fallon.
In this live webinar, I welcomed two esteemed guests with over 20 years combined experience in corporate development to break down strategies and processes and discuss their insights. Click to watch the full recording.
In this episode, we speak with Erez Naaman, Co-Founder & CTO at Scopio Labs, about what to introduction of AI means for the future of the diagnostics market.
Comments.